Abstract

BackgroundLater life metabolic dysfunction is a well-recognised consequence of being born Small for Gestational Age (SGA). This study has applied metabolomics to identify whether there are changes in these pathways in pre-pubertal short SGA children and aimed to compare the intracellular and extracellular metabolome in fibroblasts derived from healthy children and SGA children with post-natal growth impairment.MethodsSkin fibroblast cell lines were established from eight SGA children (age 1.8 -10.3 years) with failure of catch-up growth and from three healthy control children. Confluent cells were incubated in serum free media and the spent growth medium (metabolic footprint) and intracellular metabolome (metabolic fingerprint) were analysed by gas-chromatography mass spectrometry.Results19 metabolites were significantly altered between SGA and control cell lines. The greatest fold difference (FD) was seen for alanine (fingerprint FD, SGA: control) 0.3, p=0.01 and footprint FD=0.19, p=0.01), aspartic acid (fingerprint FD=5.21, p=0.01) and cystine (footprint FD=1.66, p=0.02). Network analysis of the differentially expressed metabolites predicted inhibition of insulin and activation of ERK/AKT/PI3K signalling in SGA cells.ConclusionsThis study indicates that changes in cellular metabolism associated with both growth failure and insulin insensitivity are present in pre-pubertal short children born SGA.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.